Generation of T-cell-receptor-negative CD8αβ-positive CAR T cells from T-cell-derived induced pluripotent stem cells

Sjoukje J. C. van der Stegen(Memorial Sloan Kettering Cancer Center), Pieter L. Lindenbergh(Memorial Sloan Kettering Cancer Center), Roseanna M. Petrovic(Memorial Sloan Kettering Cancer Center), Hongyao Xie(Memorial Sloan Kettering Cancer Center), Mame P. Diop(Memorial Sloan Kettering Cancer Center), Vera Alexeeva(Memorial Sloan Kettering Cancer Center), Yuzhe Shi(Memorial Sloan Kettering Cancer Center), Jorge Mansilla‐Soto(Memorial Sloan Kettering Cancer Center), Mohamad Hamieh(Memorial Sloan Kettering Cancer Center), Justin Eyquem(Gladstone Institutes), Annalisa Cabriolu(Memorial Sloan Kettering Cancer Center), Xiuyan Wang(Memorial Sloan Kettering Cancer Center), Ramzey Abujarour(Fate Therapeutics (United States)), Tom T. Lee(Fate Therapeutics (United States)), Raedun Clarke(Fate Therapeutics (United States)), Bahram Valamehr(Fate Therapeutics (United States)), Maria Themeli(Amsterdam University Medical Centers), Isabelle Rivière(Memorial Sloan Kettering Cancer Center), Michel Sadelain(Memorial Sloan Kettering Cancer Center)
Nature Biomedical Engineering
August 8, 2022
Cited by 71Open Access
Full Text

Abstract


Related Papers

No related papers found

Powered by citation graph analysis